Next Article in Journal
Diabetes Mellitus and Hearing Loss: A Complex Relationship
Previous Article in Journal
A New Parameter for Calcium Oxalate Stones: Impact of Linear Calculus Density on Non-Contrast Computed Tomography
Previous Article in Special Issue
The Prone Lateral Approach for Lumbar Fusion—A Review of the Literature and Case Series
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Takeuchi et al. Predictive Factors for Poor Outcome following Chemonucleolysis with Condoliase in Lumbar Disc Herniation. Medicina 2022, 58, 1868

1
Department of Spinal Disorders Center, Fujieda Heisei Memorial Hospital, Shizuoka 426-8662, Japan
2
Department of Neurosurgery, Shizuoka General Hospital, Shizuoka 420-8527, Japan
3
Department of Neurosurgery, Saitama Red Cross Hospital, Saitama 330-0081, Japan
*
Author to whom correspondence should be addressed.
Medicina 2023, 59(2), 268; https://doi.org/10.3390/medicina59020268
Submission received: 16 January 2023 / Accepted: 17 January 2023 / Published: 30 January 2023
(This article belongs to the Special Issue New Advance in Minimally Invasive Spine Surgery)
In the original publication [1], there was a mistake in the legend for “Figure 3. Change Illustrative example of a patient in the poor group with a calcified disc herniation. T2-weighted sagittal (A) and axial (B) magnetic resonance images show an L5/S1 disc herniation. Sagittal (C) and axial (D) computed tomography myelography helped to confirm the calcified disc herniation”. The word change was added by mistake. The correct legend is shown below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Figure 3. Illustrative example of a patient in the poor group with a calcified disc herniation. T2-weighted sagittal (A) and axial (B) magnetic resonance images show an L5/S1 disc herniation. Sagittal (C) and axial (D) computed tomography myelography helped to confirm the calcified disc herniation.”

Reference

  1. Takeuchi, S.; Hanakita, J.; Takahashi, T.; Inoue, T.; Minami, M.; Suda, I.; Nakamura, S.; Kanematsu, R. Predictive Factors for Poor Outcome following Chemonucleolysis with Condoliase in Lumbar Disc Herniation. Medicina 2022, 58, 1868. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Takeuchi, S.; Hanakita, J.; Takahashi, T.; Inoue, T.; Minami, M.; Suda, I.; Nakamura, S.; Kanematsu, R. Correction: Takeuchi et al. Predictive Factors for Poor Outcome following Chemonucleolysis with Condoliase in Lumbar Disc Herniation. Medicina 2022, 58, 1868. Medicina 2023, 59, 268. https://doi.org/10.3390/medicina59020268

AMA Style

Takeuchi S, Hanakita J, Takahashi T, Inoue T, Minami M, Suda I, Nakamura S, Kanematsu R. Correction: Takeuchi et al. Predictive Factors for Poor Outcome following Chemonucleolysis with Condoliase in Lumbar Disc Herniation. Medicina 2022, 58, 1868. Medicina. 2023; 59(2):268. https://doi.org/10.3390/medicina59020268

Chicago/Turabian Style

Takeuchi, Shu, Junya Hanakita, Toshiyuki Takahashi, Tomoo Inoue, Manabu Minami, Izumi Suda, Sho Nakamura, and Ryo Kanematsu. 2023. "Correction: Takeuchi et al. Predictive Factors for Poor Outcome following Chemonucleolysis with Condoliase in Lumbar Disc Herniation. Medicina 2022, 58, 1868" Medicina 59, no. 2: 268. https://doi.org/10.3390/medicina59020268

Article Metrics

Back to TopTop